Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases

Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases

US Patent 7189518 · Granted Mar 13, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid t2023
Relevance of achieved levels of markers of systemic inflammation following treat2022
Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid t2020
Relevance of achieved levels of markers of systemic inflammation following treat2015
Inflammatory markers as tools in the detection and prevention of diabetes mellit2012
Systemic inflammatory markers as diagnostic tools in the prevention of atheroscl2011
Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid t2011
Systematic inflammatory markers as diagnostic tools in the prevention of atheros2006
Suppression of vascular disorders by mucosal administration of heat shock protei2004
Methods of treating vascular disease associated with cystatin C deficiency2004
Systemic inflammatory markers as diagnostic tools in the prevention of atheroscl2000